ISPAD Scientific Visiting Fellowships

2009
Mari Pulkkinen, Helsinki, Finland for the project “IGF-1 as a Mediator of Metabolic Control in Type 1 Diabetic Patients” to be performed at Karolinska Institute, Stockholm, Sweden.

2006
Catarina Limbert, Lisboa, Portugal, to study Cell-replacementtherapy of type 1 diabetes – the potential of human mesenchymal (hMSC) adult stem cells’ at the Division of Metabolism, Endocrinology and Molecular Medicine, University of Wuerzburg, Germany.

Miguel Pinto, Quito, Ecuador, to study _Autoimmunity pattern as risk factor to develop type 1 diabetes in children with high genetic risk’ at the Department of Pediatrics, University of Turku, Finland.

2005
Dorothee Deiss, Berlin, Germany, to study “Control of Hyperglycemia in the Pediatric Intensive Care Unit” at the Lucile S. Packard Children´s Hospital, Stanford University School, Palo Alto, CA, U.S.A.

Chunhua Zeng, Guangzhou, China, to study “Prevention and treatment of Type 1 diabetes mellitus in NOD mice” at the Department of Human Genetics, University of Michigan, MI, U.S.A

Yelena Vainilovich, Minsk, Belarus, to study “Beta-cell Functioning in the Early Phases of Human Prediabetes. An IVGTTbased
Study” at the University of Turku, Finland.

2004

Rasa Verkauskiene, Kaunas, Lithuania to pursue research in Paris with Claire Levy-Marchal and Paul Czernichow on insulin resistance and type 2 diabetes.

2003

Annabelle Slingerland, Rotterdam, The Netherlands, to Exeter University, England to study further the clinical, physiological and genetic characteristics of the newly described Permanent Neonatal Diabetes gene Kir6.2. Report

ISPAD Alan Drash Clinical Fellowships

2009

Oburo Ofumbi Geoffrey, Kampala, Uganda for a clinical visit with Dr. Kaushik Ramaiya in Dar el Salaam, Tanzania.

2008

Menang Joshua Ngwang, Cameroon, for participating in a diabetes research course in Vienna.